- Meeting Report
- Open Access
- Published:
Abstract 2: First-phase ejection fraction is a powerful predictor of adverse events in asymptomatic patients with aortic stenosis and preserved total ejection fraction
Echo Research & Practice volume 7, pages M7–M8 (2020)
Funding
This work did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.
Author information
Authors and Affiliations
Rights and permissions
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.(http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
About this article
Cite this article
Gu, H., Saeed, S., Boguslavskyi, A. et al. Abstract 2: First-phase ejection fraction is a powerful predictor of adverse events in asymptomatic patients with aortic stenosis and preserved total ejection fraction. Echo Res Pract 7, M7–M8 (2020). https://doi.org/10.1007/BF03651754
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03651754